Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Dragon Pharmaceutical (OTC BB:DRUG.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider | Financials
Location
543 Granville Street, Suite 1200
Vancouver, Canada
Phone: (604) 669-8817
Email: shaun@dragonbiotech.com
Employees (last reported count): 3
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 65%
·Institutional: 2% (5% of float)
(6 institutions)
·Net Inst. Selling: 106.0K shares (+48.62%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Dragon Pharmaceuticals Inc. is a development stage pharmaceutical and biotechnological company whose business plan is to develop, manufacture and market pharmaceutical products in China. The Company own a 75% interest in a drug manufacturing company called Nanjing Huaxin Biotech Co. Ltd. located in Nanjing City, China and is currently implementing its proprietary technology which will allow Nanjing Huaxin Biotech to produce drugs such as EPO in an efficient and cost-effective manner. The Company's strategy is to use its biotechnological expertise to produce and market pharmaceutical products primarily in China at costs that will be lower than those currently available.
More from Market Guide: Expanded Business Description

Financial Summary
Dragon Pharmaceutical is a development stage pharmaceutical and biotechnological company whose business plan is to develop, manufacture and market pharmaceutical products in China. For the six months ended 6/30/01, sales decreased 13% to $1.3 million. Net loss totaled $1.8 million, up from $404 thousand. Revenues reflect reduced sales of EPO in China. Loss also reflects increased production, administrative, research and new market development expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Longbin Liu, M.D., 37
Pres, CEO, Director
$72K
Ken Cai, Ph.D., 35
CFO, Director
--  
Rita Jervis
VP, Devel.
--  
Shaun Maskerine, 32
Sec., Treasurer
--  
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:DRUG.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-May-2001
$1.40 
Recent Price$2.24 
52-Week High
on 7-Sep-2000
$4.25 
Beta2.03 
Daily Volume (3-month avg)149.0K
Daily Volume (10-day avg)40.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-45.7%
52-Week Change
relative to S&P500
-27.1%
Share-Related Items
Market Capitalization$37.7M
Shares Outstanding16.8M
Float5.90M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.73 
Earnings (ttm)-$0.21 
Earnings (mrq)-$0.06 
Sales (ttm)$0.17 
Cash (mrq)$0.14 
Valuation Ratios
Price/Book (mrq)3.07 
Price/EarningsN/A 
Price/Sales (ttm)13.48 
Income Statements
Sales (ttm)$2.98M
EBITDA (ttm)-$4.07M
Income available to common (ttm)-$4.17M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-25.68%
Return on Equity (ttm)-30.39%
Financial Strength
Current Ratio (mrq)1.56 
Debt/Equity (mrq)0.27 
Total Cash (mrq)$2.27M
Short Interest
Shares ShortN/A 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.